Table 1.
Baseline characteristics between race and urinary manifestations
| African Americans N = 1175 |
Caucasian Americans N = 1929 |
p value | Total N = 3104 |
|
|---|---|---|---|---|
| Mean age ± SD | 47.7 ± 19.2 | 46.2 ± 19.9 | 0.042 | 46.7 ± 19.7 |
| Female sex, N (%) | 732 (62%) | 1110 (58%) | 0.009 | 1842 (59%) |
| Crohn’s disease | 691 (59%) | 1087 (56%) | 0.18 | 1778 (57%) |
| Ulcerative colitis | 484 (41%) | 842 (44%) | 0.18 | 1326 (43%) |
| Average # of corticosteroid prescriptions ± SD | 1.8 ± 4.4 | 1.41 ± 3.6 | 0.008 | 1.56 ± 3.9 |
| # of patients prescribed Aminosalicylates, N (%) | 348 (30.2%) | 638 (33.6%) | 0.050 | 986 (32.3%) |
| # of patients prescribed corticosteroid. N (%) | 413 (35.9%) | 633 (33.4%) | 0.16 | 1046 (34.3%) |
| Overall urolithiasis, N (%) | 64 (5.4%) | 135 (7.0%) | 0.09 | 199 (6.4%) |
| Overall uncomplicated urinary tract infections, N (%) | 228 (19.4%) | 243 (12.6%) | < 0.001 | 471 (15.2%) |
| Urolithiasis with CD, N (%) | 38 (5.5%) | 81 (7.5%) | 0.11 | 119 (6.7%) |
| Uncomplicated urinary tract infections with CD, N (%) | 128 (18.5%) | 136 (12.5%) | 0.001 | 264 (14.9%) |
| Urolithiasis with UC, N (%) | 26 (5.4%) | 54 (6.4%) | 0.44 | 80 (6.0%) |
| Uncomplicated urinary tract infections with UC, N (%) | 100 (20.7%) | 107 (12.7%) | < 0.001 | 207 (8.4%) |